Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.
OBJECTIVE
To compare Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients in different age groups and from different biopsy sites.


METHODS
The biopsy specimens were taken from the antrum, corpus and upper angulus of gastric ulcer and chronic gastritis patients. Giemsa staining, improved Toluidine-blue staining and H pylori-specific antibody immune staining were performed as appropriate for the histological diagnosis of H pylori infection. Hematoxylin-eosin staining was used for the histological diagnosis of activity of H pylori infection, mucosal inflammation, glandular atrophy and intestinal metaplasia and scored into four grades according to the Updated Sydney System.


RESULTS
Total rate of H pylori infection, mucosal inflammation, activity of H pylori infection, glandular atrophy and intestinal metaplasia in 3 839 gastric ulcer patients (78.5%, 97.4%, 82.1%, 61.1% and 64.2%, respectively) were significantly higher than those in 4 102 chronic gastritis patients (55.0%, 90.3%, 56.2%, 36.8%, and 37.0%, respectively, P<0.05). The rate of H pylori colonization of chronic gastritis in <30 years, 31-40 years, 41-50 years, 51-60 years, 61-70 years and >70 years age groups in antrum was 33.3%, 41.7%, 53.6%, 57.3%, 50.7%, 43.5%, respectively; in corpus, it was 32.6%, 41.9%, 53.8%, 60.2%, 58.0%, 54.8%, respectively; in angulus, it was 32.4%, 42.1%, 51.6%, 54.5%, 49.7%, 43.5%, respectively. The rate of H pylori colonization of gastric ulcer in <30 years, 31-40 years, 41-50 years, 51-60 years, 61-70 years and >70 years age groups in antrum was 60.5%, 79.9%, 80.9%, 66.8%, 59.6%, 45.6%, respectively; in corpus, it was 59.7%, 79.6%, 83.6%, 80.1%, 70.6%, 59.1%, respectively; in angulus, it was 61.3%, 77.8%, 75.3%, 68.8%, 59.7%, 45.8%, respectively. The rate of H pylori colonization at antrum was similar to corpus and angulus in patients, below 50 years, with chronic gastritis and in patients, below 40 years, with gastric ulcer. In the other age- groups, the rate of H pylori colonization was highest in corpus, lower in antrum and lowest in angulus (all P<0.05). The rates of glandular atrophy and intestinal metaplasia were higher and earlier in H pylori-positive patients than those without H pylori infection (both P<0.01). In comparison of gastric ulcer patients with chronic gastritis patients, the rate of glandular atrophy and intestinal metaplasia was higher in H pylori-positive patients with gastric ulcer than in H pylori-positive patients with chronic gastritis (both P<0.01); the rate of glandular atrophy and intestinal metaplasia were also higher in H pylori-negative patients with gastric ulcer than in H pylori-negative patients with chronic gastritis (both P<0.01). Both glandular atrophy and intestinal metaplasia were much more commonly identified in the angulus than in the antrum, lowest in corpus (all P<0.01).


CONCLUSIONS
Rate of H pylori infection, glandular atrophy and intestinal metaplasia in gastric ulcer were higher than in chronic gastritis in all-different age -groups. Distribution of H pylori colonization is pangastric in the younger patients. It is highest in corpus, lower in antrum and lowest in angulus in the older age groups. Progression of glandular atrophy and intestinal metaplasia seem to have a key role in the distribution of H pylori colonization. H pylori appears to be the most important risk factor for the development of glandular atrophy and intestinal metaplasia, but it is not the only risk.
Zhang
Chuan
C
Department of Gastroenterology, Baogang Hospital, Shanghai Second Medical University, Shanghai 201900, China. zhangchuan71@hotmail.com
Yamada
Nobutaka
N
Wu
Yun-Lin
YL
Wen
Min
M
Matsuhisa
Takeshi
T
Matsukura
Norio
N
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy; D001706:Biopsy; D002648:Child; D002908:Chronic Disease; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology*; D005756:Gastritis / Q000453:epidemiology / Q000382:microbiology / Q000473:pathology*; D016481:Helicobacter Infections / Q000453:epidemiology / Q000473:pathology*; D016480:Helicobacter pylori; D006801:Humans; D007422:Intestines / Q000473:pathology; D008297:Male; D008679:Metaplasia; D008875:Middle Aged; D012307:Risk Factors; D013276:Stomach Ulcer / Q000453:epidemiology / Q000473:pathology*
Aliment Pharmacol Ther. 2001 Sep;15(9):1271-90
11552897
J Gastroenterol Hepatol. 2000 Mar;15(3):271-6
10764027
J Clin Pathol. 2000 Oct;53(10):756-9
11064668
Gastroenterology. 1995 Sep;109(3):681-91
7657096
Scand J Gastroenterol. 1999 Sep;34(9):864-9
10522603
Infect Immun. 1990 Mar;58(3):603-10
2307514
Lancet. 2002 Sep 21;360(9337):933-41
12354485
Scand J Gastroenterol. 2002 Mar;37(3):262-6
11916187
Lancet. 1991 Nov 9;338(8776):1175-6
1682595
Gastroenterology. 1997 Dec;113(6):1983-91
9394739
Gastroenterology. 1998 Jan;114(1):50-7
9428218
Gastroenterology. 1972 Oct;63(4):584-92
5077145
Scand J Gastroenterol. 2003 May;38(5):491-7
12795458
Scand J Gastroenterol. 2001 Feb;36(2):136-43
11252404
J Clin Gastroenterol. 2002 Sep;35(3):234-9
12192199
Nihon Rinsho. 2002 Feb;60 Suppl 2:614-8
11979857
Keio J Med. 2002 Dec;51 Suppl 2:40-4
12528936
J Clin Pathol. 1989 Dec;42(12):1269-71
2613920
Curr Opin Infect Dis. 2003 Oct;16(5):445-51
14501997
Gut. 2002 Sep;51(3):351-5
12171955
Gut. 1967 Oct;8(5):497-508
6057781
Lancet. 1984 Jun 16;1(8390):1311-5
6145023
Dig Dis Sci. 1990 Apr;35(4):433-8
2318088
Recenti Prog Med. 2004 May;95(5):239-44
15202673
Gut. 1997 Jul;41(1):8-13
9274464
Gut. 1995 Jan;36(1):12-6
7890214
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S11-5
8574729
Gut. 1993 Aug;34(8):1032-7
8174948
Curr Gastroenterol Rep. 2000 Dec;2(6):494-8
11079052
Gastroenterology. 1999 May;116(5):1217-29
10220514
Clin Infect Dis. 2002 Aug 1;35(3):298-304
12115096
J Natl Cancer Inst. 2002 Nov 20;94(22):1680-7
12441323
JAMA. 1994 Jul 6;272(1):65-9
8007082